Clinical Trial Update: The Effect of Galactooligosaccharides (GOS) on the Gut Microbiota of Lactose Intolerance Individuals [NA]

View source ↗

Summary

A completed clinical trial evaluated the impact of galactooligosaccharides (GOS) on the gut microbiota of individuals with lactose intolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lactose Intolerance

Drugs mentioned

• Galactooligosaccharides (GOS) (galactooligosaccharides)

Snippet

Sponsor: Oregon State University | Conditions: Modulation of the Human Gut Microbiota by Prebiotic Galactooligosaccharides (GOS) | NA | Status: COMPLETED